Table 4.
Marker | Cut-off value | Sensitivity (%) | Specificity (%) | AUC | P | 95% CI* |
---|---|---|---|---|---|---|
AY group | ||||||
Cer(d18:0/16:0) | 1,385,000 | 100.00 | 42.11 | 0.671 | 0.292 | 0.411–0.931 |
Cer(t18:0/12:0) | 465,214 | 75.00 | 78.95 | 0.750 | 0.123 | 0.421–1.079 |
Sphinganine | 8,950,000 | 75.00 | 73.68 | 0.711 | 0.194 | 0.474–0.947 |
SY group | ||||||
Cer(d18:0/16:0) | 1,170,000 | 100.00 | 66.67 | 0.778 | 0.089 | 0.589–0.967 |
Cer(t18:0/12:0) | 462,514 | 100.00 | 72.22 | 0.833 | 0.041 | 0.654–1.103 |
Sphinganine | 7,430,000 | 100.00 | 66.67 | 0.806 | 0.061 | 0.622–0.989 |
*Null hypothesis: True area: 0.5. CI: Confidence interval; ROC: Receiver operating characteristic; MACE: Major adverse cardiovascular events; AUC: Area under curve; Cer: Ceramide.